Shurtleff, Valerie W.; Layton, Mark E.; Parish, Craig A.; Perkins, James J.; Schreier, John D. et al. (2024). Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.3c02248. [PDB: 8ute] |
CMCF-BM |
Peer-Reviewed Article |
Health |
Xu, Shangyi; Grochulski, Pawel; Tanaka, Takuji (2024). Structural basis for the allosteric behaviour and substrate specificity of Lactococcus lactis Prolidase. Biochimica et Biophysica Acta - Proteins and Proteomics 1872(3) , 141000. 10.1016/j.bbapap.2024.141000. |
CMCF-BM, CMCF-ID |
Peer-Reviewed Article |
Health |
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. |
BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM |
Peer-Reviewed Article |
Health |
Sankhe, Safiétou; Fofana, Fatoumata G.; Heiba, Walid; Ogunyemi, Oludare M.; Masisi, Kabo et al. (2025). BioStruct-Africa’s capacity building workshops as a model for advancing the emerging community of structural biologists in Africa. Communications Chemistry 8(1) . 10.1038/s42004-025-01519-w. |
CMCF |
Peer-Reviewed Article |
Health |
Daniel-Ivad, Phillip; Ryan, Katherine S. (2024). Structure of methyltransferase RedM that forms the dimethylpyrrolinium of the bisindole reductasporine. Journal of Biological Chemistry 300(1) , 105520. 10.1016/j.jbc.2023.105520. |
CMCF |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
8
H
14
N
2
(SO
4
). Powder Diffraction , 1-5. 10.1017/s0885715625000545. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
19
H
21
N
4
O)(C
7
H
7
O
3
S)(H
2
O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. |
BXDS-WLE |
Peer-Reviewed Article |
Health |